Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

被引：0

作者：

Felipe Alvarez-Manceñido

Paula Jimenez-Fonseca

Alberto Carmona-Bayonas

Virginia Arrazubi

Raquel Hernandez

Juana M. Cano

Ana Custodio

Carles Pericay Pijaume

Gema Aguado

Nieves Martínez Lago

Manuel Sánchez Cánovas

Diego Cacho Lavin

Laura Visa

Alba Martinez-Torron

Aranzazu Arias-Martinez

Flora López

M. Luisa Limón

Rosario Vidal Tocino

Ana Fernández Montes

Maria Alsina

Paola Pimentel

Pablo Reguera

Alfonso Martín Carnicero

Avinash Ramchandani

Mónica Granja

Aitor Azkarate

Marta Martín Richard

Olbia Serra

Carolina Hernández Pérez

Alicia Hurtado

Aitziber Gil-Negrete

Tamara Sauri

Patricia Morales del Burgo

Javier Gallego

机构：

[1] Hospital Universitario Central de Asturias,Pharmacy Department

[2] Hospital Universitario Central de Asturias,Medical Oncology Department

[3] ISPA,Hematology and Medical Oncology Department

[4] Hospital Universitario Morales Meseguer,Medical Oncology Department

[5] University of Murcia,Medical Oncology Department

[6] IMIB,Medical Oncology Department

[7] Complejo Hospitalario de Navarra,Medical Oncology Department

[8] Hospital Universitario de Canarias,Medical Oncology Department

[9] Hospital General Universitario de Ciudad Real,Medical Oncology Department

[10] Hospital Universitario La Paz,Medical Oncology Department

[11] CIBERONC CB16/12/00398,Hematology and Medical Oncology Department

[12] Hospital Universitario Parc Tauli,Medical Oncology Department

[13] Hospital Universitario Gregorio Marañón,Medical Oncology Department

[14] Complejo Hospitalario Universitario de A Coruña,Pharmacy Department

[15] Hospital Universitario Morales Meseguer,Medical Oncology Department

[16] Hospital Universitario Marqués de Valdecilla,Medical Oncology Department

[17] IDIVAL,Medical Oncology Department

[18] Hospital Universitario El Mar,Medical Oncology Department

[19] Hospital Universitario Marqués de Valdecilla,Medical Oncology Department

[20] Hospital Universitario Doce de Octubre,Medical Oncology Department

[21] Hospital Universitario Virgen del Rocío,Medical Oncology Department

[22] Complejo Asistencial Universitario de Salamanca-IBSAL,Medical Oncology Department

[23] Complejo Hospitalario de Orense,Medical Oncology Department

[24] Hospital Universitario Vall d’Hebron,Medical Oncology Department

[25] Vall Hebron Institute of Oncology (VHIO),Medical Oncology Department

[26] Hospital General Universitario Santa Lucía,Medical Oncology Department

[27] Hospital Universitario Ramón y Cajal,Medical Oncology Department

[28] Hospital San Pedro,Medical Oncology Department

[29] Hospital Universitario Insular de Gran Canaria,Medical Oncology Department

[30] Hospital Universitario Clínico San Carlos,Medical Oncology Department

[31] Hospital Universitario Son Espases,Medical Oncology Department

[32] Hospital Universitario Santa Creu i Sant Pau,Pathology Department

[33] Catalan Institute of Oncology,Medical Oncology Department

[34] Hospital Universitario Nuestra Señora de la Candelaria,undefined

[35] Hospital Universitario Fundación Alcorcón,undefined

[36] Hospital Universitario Donostia,undefined

[37] Hospital Clinic,undefined

[38] IDIBAPS,undefined

[39] Hospital Universitario Central de Asturias,undefined

[40] Hospital General Universitario de Elche,undefined

来源：

Gastric Cancer | 2021年 / 24卷

关键词：

Esophageal adenocarcinoma; Chemotherapy; Gastric cancer; Gastroesophageal junction; Trastuzumab; Survival; Prognosis; Advanced cancer; Lauren type; Erbb;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：926 / 936

页数：10

共 50 条

[11] Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry
Viudez, A.
Carmona-Bayonas, A.
Gallego, J.
Lacalle, A.
Hernandez, R.
Cano, J. M.
Macias, I
Custodio, A.
Martinez de Castro, E.
Sanchez, A.
Iglesia, L.
Reguera, P.
Visa, L.
Azkarate, A.
Sanchez-Canovas, M.
Mangas, M.
Limon, M. L.
Martinez-Torron, A.
Asensio, E.
Ramchandani, A.
Martin-Carnicero, A.
Hurtado, A.
Cerda, P.
Garrido, M.
Sanchez-Bayonas, R.
Serrano, R.
Jimenez-Fonseca, P.
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (05) : 734 - 750
[12] Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
Jimenez Fonseca, Paula
Carmona-Bayonas, Alberto
Hernandez, Raquel
Custodio, Ana
Maria Cano, Juana
Lacalle, Alejandra
Echavarria, Isabel
Macias, Ismael
Mangas, Monserrat
Visa, Laura
Buxo, Elvira
Alvarez Mancenido, Felipe
Viudez, Antonio
Pericay, Carles
Azkarate, Aitor
Ramchandani, Avinash
Lopez, Carlos
Martinez de Castro, Eva
Fernandez Montes, Ana
Longo, Federico
Sanchez Bayona, Rodrigo
Luisa Limon, Maria
Diaz-Serrano, Asun
Martin Carnicero, Alfonso
Arias, David
Cerda, Paula
Rivera, Fernando
Maria Vieitez, Jose
Sanchez Canovas, Manuel
Garrido, M.
Gallego, J.
[J]. BRITISH JOURNAL OF CANCER, 2017, 117 (06) : 775 - 782
[13] Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
Paula Jiménez Fonseca
Alberto Carmona-Bayonas
Raquel Hernández
Ana Custodio
Juana Maria Cano
Alejandra Lacalle
Isabel Echavarria
Ismael Macias
Monserrat Mangas
Laura Visa
Elvira Buxo
Felipe Álvarez Manceñido
Antonio Viudez
Carles Pericay
Aitor Azkarate
Avinash Ramchandani
Carlos López
Eva Martinez de Castro
Ana Fernández Montes
Federico Longo
Rodrigo Sánchez Bayona
Maria Luisa Limón
Asun Diaz-Serrano
Alfonso Martin Carnicero
David Arias
Paula Cerdà
Fernando Rivera
Jose Maria Vieitez
Manuel Sánchez Cánovas
M Garrido
J Gallego
[J]. British Journal of Cancer, 2017, 117 : 775 - 782
[14] Should Adenocarcinoma of the Esophagogastric Junction Be Classified as Gastric or Esophageal Cancer, or Else as a Distinct Clinical Entity?
Pedrazzani, Corrado
[J]. ANNALS OF SURGERY, 2015, 261 (04) : E107 - E108
[15] Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
Wang, Lei
Sun, Mengting
Li, Jinyang
Wan, Linghong
Tan, Yuting
Tian, Shuoran
Hou, Yongying
Wu, Linyu
Peng, Ziyi
Hu, Xiao
Zhang, Qihua
Huang, Zening
Han, Mengyi
Peng, Shiyin
Pan, Yuwei
Ren, Yuanfeng
Zhang, Mengsi
Chen, Dongfeng
Liu, Qin
Li, Xianfeng
Qin, Zhong-yi
Xiang, Junyv
Li, Mengxia
Zhu, Jianwu
Chen, Qiyue
Luo, Huiyan
Wang, Shunan
Wang, Tao
Li, Fan
Bian, Xiu-wu
Wang, Bin
[J]. CLINICAL CANCER RESEARCH, 2025, 31 (01) : 74 - 86
[16] Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit
Kalff, Marianne C.
Wagner, Anna D.
Verhoeven, Rob H. A.
Lemmens, Valery E. P. P.
van Laarhoven, Hanneke W. M.
Gisbertz, Suzanne S.
van Berge Henegouwen, Mark I.
[J]. GASTRIC CANCER, 2022, 25 (01) : 22 - 32
[17] Current prognostic factors of advanced gastric cancer patients treated with chemotherapy: real world data from a Japanese 12 institutions
Yamamoto, Shumpei
Kanzaki, Hiromitsu
Sakaguchi, Chihiro
Mouri, Hirokazu
Tsuzuki, Takao
Nasu, Junichiro
Kobayashi, Sayo
Toyokawa, Tatsuya
Obayashi, Yuka
Inoue, Masafumi
Kato, Ryo
Matsubara, Minoru
Kita, Masahide
Okada, Hiroyuki
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (10) : 928 - 935
[18] Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649
Moehler, Markus
Xiao, Hong
Blum, Steven I.
Elimova, Elena
Cella, David
Shitara, Kohei
Ajani, Jaffer A.
Janjigian, Yelena Y.
Garrido, Marcelo
Shen, Lin
Yamaguchi, Kensei
Liu, Tianshu
Schenker, Michael
Kowalyszyn, Ruben
Bragagnoli, Arinilda Campos
Bruges, Ricardo
Montesarchio, Vincenzo
Pazo-Cid, Roberto
Hunter, Shannon
Davenport, Eric
Wang, Jinyi
Kondo, Kaoru
Li, Mingshun
Wyrwicz, Lucjan
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (35) : 5388 - +
[19] New metastatic lymph node classification for early gastric cancer should differ from those for advanced gastric adenocarcinoma: Results based on the SEER database
Lin, Jian-Xian
Lin, Jun-Peng
Li, Ping
Xie, Jian-Wei
Wang, Jia-Bin
Lu, Jun
Chen, Qi-Yue
Cao, Long-Long
Lin, Mi
Tu, Ru-Hong
Zheng, Chao-Hui
Huang, Chang-Ming
[J]. WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (02) : 145 - 155
[20] Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States
Hess, Lisa M.
Grabner, Michael
Wang, Liya
Liepa, Astra M.
Li, Xiaohong Ivy
Cui, Zhanglin Lin
Bowman, Lee
Schelman, William R.
[J]. PRAGMATIC AND OBSERVATIONAL RESEARCH, 2020, 11 : 27 - 43

← 1 2 3 4 5 →